Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

4
results for

"Seong Gyu Hwang"

Article category

Keywords

Publication year

"Seong Gyu Hwang"

Original Article

Viral hepatitis

Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kwang-il Kim, Soo-Hwan Kim, Kyu Sung Rim, Seong Gyu Hwang
Clin Mol Hepatol 2019;25(1):52-64.
Published online October 23, 2018
DOI: https://doi.org/10.3350/cmh.2018.0040
Background/Aims
Nonalcoholic fatty liver disease (NAFLD) is becoming a worldwide epidemic, and is frequently found in patients with chronic hepatitis B (CHB). We investigated the impact of histologically proven hepatic steatosis on the risk for hepatocellular carcinoma (HCC) in CHB patients without excessive alcohol intake.
Methods
Consecutive CHB patients who underwent liver biopsy from January 2007 to December 2015 were included. The association between hepatic steatosis (≥ 5%) and subsequent HCC risk was analyzed. Inverse probability weighting (IPW) using the propensity score was applied to adjust for differences in patient characteristics, including metabolic factors.
Results
Fatty liver was histologically proven in 70 patients (21.8%) among a total of 321 patients. During the median (interquartile range) follow-up of 5.3 (2.9–8.3) years, 17 of 321 patients (5.3%) developed HCC: 8 of 70 patients (11.4%) with fatty liver and 9 of 251 patients (3.6%) without fatty liver. The five-year cumulative incidences of HCC among patients without and with fatty liver were 1.9% and 8.2%, respectively (P=0.004). Coexisting fatty liver was associated with a higher risk for HCC (adjusted hazards ratio [HR], 3.005; 95% confidence interval [CI], 1.122–8.051; P=0.03). After balancing with IPW, HCC incidences were not significantly different between the groups (P=0.19), and the association between fatty liver and HCC was not significant (adjusted HR, 1.709; 95% CI, 0.404–7.228; P=0.47).
Conclusions
Superimposed NAFLD was associated with a higher HCC risk in CHB patients. However, the association between steatosis per se and HCC risk was not evident after adjustment for metabolic factors.

Citations

Citations to this article as recorded by  Crossref logo
  • High serum growth differentiation factor 15 is a risk factor for the occurrence of hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs
    Emi Sometani, Hayato Hikita, Kazuhiro Murai, Hidenori Toyoda, Satoshi Tanaka, Tsugiko Oze, Jihyun Sung, Akiyoshi Shimoda, Makoto Fukuoka, Satoshi Shigeno, Keisuke Fukutomi, Kumiko Shirai, Yuki Tahata, Yoshinobu Saito, Akira Nishio, Kunimaro Furuta, Takahi
    Hepatology Research.2025; 55(1): 22.     CrossRef
  • Risk Stratification of Metabolic Risk Factors and Statin Use Associated With Liver and Nonliver Outcomes in Chronic Hepatitis B
    Xinrong Zhang, Vy H Nguyen, Leslie Yeeman Kam, Scott D Barnett, Linda Henry, Ramsey Cheung, Mindie H Nguyen
    The Journal of Infectious Diseases.2025; 231(4): 1079.     CrossRef
  • Coexisting steatotic liver disease is not associated with long-term liver-related events in patients with chronic hepatitis B
    Navavee Uman, Apichat Kaewdech, Pimsiri Sripongpun, Naichaya Chamroonkul, Teerha Piratvisuth
    Gastroenterology Report.2025;[Epub]     CrossRef
  • Association of concomitant MASLD and hepatitis B virus with clinical prognosis in hepatocellular carcinoma after curative resection
    Chih-Jan Ko
    American Journal of Cancer Research.2025; 15(2): 737.     CrossRef
  • Study on Ultrasound-Assisted Diagnosis of CHB Complicated with NAFLD Hepatic Fibrosis Based on Deep Learning
    Xiuling Huang, Shan Huang, Changfeng Dong, Nuo Chen, Yuxuan Wang, Changmiao Wang, Yongquan Zhang, Cheng Feng
    Journal of Imaging Informatics in Medicine.2025; 38(6): 4349.     CrossRef
  • The outcomes and mechanisms of chronic hepatitis B complicated by metabolic dysfunction-associated steatotic liver disease
    Mao-Ping Li, Kai-Zhong Luo
    Hepatobiliary & Pancreatic Diseases International.2025; 24(5): 476.     CrossRef
  • Impact of Metabolic Dysfunction-Associated Fatty Liver Disease of Varying Severity on Antiviral Treatment Outcomes and Clinical Prognosis in Patients with Chronic Hepatitis B: A Systematic Review and Meta-analysis
    Qianqian Zhu, Chengde Su, Mingdan Li, Yali Xu, Qian Liu, Ying Zhang, Xinyi Zhang, Qiuxiang Li, Huajun Wang, Yawen Luo, Ping Yang
    Infectious Diseases and Therapy.2025; 14(8): 1599.     CrossRef
  • Chronic hepatitis B: Is it time for expanded antiviral treatment?
    Manish Manrai, Atul A Jha, Aditya V Pachisia, Saurabh Dawra
    World Journal of Virology.2025;[Epub]     CrossRef
  • Hepatocellular carcinoma risk stratification to identify patients suitable for intensive surveillance in viral hepatitis: the SELECT score
    Yeun-Yoon Kim, Won Chang, Jeong Min Lee, Se Woo Kim, Jae Seok Bae, Jeongin Yoo, Sun Kyung Jeon, HeeSoo Kim, Young Hoon Kim, Jin-Young Choi, Eun Ju Cho, Yun Bin Lee, Sook-Hyang Jeong, Do Young Kim, Yunhee Choi, Jeong Hee Yoon
    European Radiology.2025;[Epub]     CrossRef
  • Influence of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with HBV-related acute-on-chronic liver failure
    Rui-Min Lai, Li-Xi Yao, Shan Lin, Jia-Hui Zhou, Bing-Ping Liu, Zhao-Yi Liang, Tianbin Chen, Jia-Ji Jiang, Qi Zheng, Yueyong Zhu
    Expert Review of Gastroenterology & Hepatology.2024; 18(1-3): 103.     CrossRef
  • Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients
    Yu-Tong Sun, Qian-Qian Chen
    World Journal of Hepatology.2024; 16(1): 109.     CrossRef
  • Effect of metabolic dysfunction‑associated fatty liver disease on the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A systematic review and meta‑analysis
    Sixing Shen, Lingyan Pan
    Experimental and Therapeutic Medicine.2024;[Epub]     CrossRef
  • Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B
    Danny Con, Steven Tu, Daniel Clayton-Chubb, John S. Lubel, Amanda J. Nicoll, Rohit Sawhney, Stephen Bloom
    Digestive Diseases and Sciences.2024; 69(4): 1496.     CrossRef
  • Influence of nonalcoholic fatty liver disease on response to antiviral treatment in patients with chronic hepatitis B: A meta-analysis
    Shi-Yi Liu, Dian Wang, Jing Liu, Lu-Ping Yang, Gong-Ying Chen
    World Journal of Hepatology.2024; 16(3): 465.     CrossRef
  • Navigating the Nomenclature of Liver Steatosis: Transitioning from NAFLD to MAFLD and MASLD - Understanding Affinities and Differences
    Apichat Kaewdech, Pimsiri Sripongpun
    Siriraj Medical Journal.2024; 76(4): 234.     CrossRef
  • Nonalcoholic fatty liver disease in Sub-Saharan Africa: A descriptive study of the range of histopathological findings in the South-West zone of Nigeria
    Olusegun Sylvester Ojo, Olusegun Adekanle, Dennis Ndububa, Olawunmi Kolawole, Omolade Adefolabi Betiku
    Nigerian Journal of Gastroenterology and Hepatology.2024; 16(1): 42.     CrossRef
  • Hepatic macrophage niche: a bridge between HBV-mediated metabolic changes with intrahepatic inflammation
    Jun Wang, Hongzhou Lu, Qian Li
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Prevalence of nonalcoholic fatty liver disease in patients with hepatitis B: A meta-analysis
    Li Zhang, Hong-Di Wu, Yuan-Fang Qian, Hong-Yan Xu
    World Journal of Clinical Cases.2024; 12(25): 5749.     CrossRef
  • Chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease: Metabolic risk factors are key drivers of hepatocellular carcinoma
    Gupse Adali, Huseyin Aykut, Nermin Mutlu Bilgic, Yusuf Yilmaz
    Heliyon.2024; 10(18): e37990.     CrossRef
  • Revolutionizing the understanding of liver disease: Metabolism, function and future
    Arnulfo E Morales-Galicia, Mariana M Ramírez-Mejía, Guadalupe Ponciano-Rodriguez, Nahum Méndez-Sánchez
    World Journal of Hepatology.2024; 16(12): 1365.     CrossRef
  • Hepatic steatosis: Ultrasound assessment using attenuation imaging (ATI) with liver biopsy correlation
    Christopher J Welman, Jacqualine Saunders, Marilyn Zelesco, Steven Abbott, Glenn Boardman, Oyekoya T Ayonrinde
    Journal of Medical Imaging and Radiation Oncology.2023; 67(1): 45.     CrossRef
  • Concomitant Diseases and Co-contribution on Progression of Liver Stiffness in Patients with Hepatitis B Virus Infection
    Chang-Hai Liu, Wei Jiang, Dong-Bo Wu, Qing-Min Zeng, You-Juan Wang, Hong Tang
    Digestive Diseases and Sciences.2023; 68(4): 1605.     CrossRef
  • The interplay of long noncoding RNAs and hepatitis B virus
    Nima Sarfaraz, Srinivas Somarowthu, Michael J. Bouchard
    Journal of Medical Virology.2023;[Epub]     CrossRef
  • Steatosis, HBV‐related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta‐analysis
    Xianhua Mao, Ka Shing Cheung, Chengzhi Peng, Lung‐Yi Mak, Ho Ming Cheng, James Fung, Noam Peleg, Howard H.‐W. Leung, Rajneesh Kumar, Jeong‐Hoon Lee, Amir Shlomai, Man‐Fung Yuen, Wai‐Kay Seto
    Hepatology.2023; 77(5): 1735.     CrossRef
  • Letter: metabolic dysfunction‐associated fatty liver disease increases risk of all‐cause mortality in patients with chronic hepatitis C
    Qianwen Zhao, Yunlei Deng
    Alimentary Pharmacology & Therapeutics.2023; 57(2): 272.     CrossRef
  • The association of fatty liver and risk of hepatocellular carcinoma in HBV or HCV infected individuals: a systematic review and meta-analysis
    Cheng-Long Han, Bao-Wen Tian, Chun-Cheng Yang, Ya-Fei Yang, Yun-Long Ma, Zi-Niu Ding, Lun-Jie Yan, Hui Liu, Zhao-Ru Dong, Zhi-Qiang Chen, Jian-Guo Hong, Dong-Xu Wang, Tao Li
    Expert Review of Gastroenterology & Hepatology.2023; 17(2): 189.     CrossRef
  • Hepatitis B virus infection combined with nonalcoholic fatty liver disease: Interaction and prognosis
    Lili Liu, Hong Li, Yang Zhang, Jing Zhang, Zhenhuan Cao
    Heliyon.2023; 9(1): e13113.     CrossRef
  • Liver fibrosis is closely related to metabolic factors in metabolic associated fatty liver disease with hepatitis B virus infection
    Haifeng Lv, Yanming Jiang, Geli Zhu, Shiyi Liu, Dian Wang, Jie Wang, Ke Zhao, Jing Liu
    Scientific Reports.2023;[Epub]     CrossRef
  • Positive hepatitis B core antibody is associated with advanced fibrosis and mortality in nonalcoholic fatty liver disease
    Pengyan Zhang, Zhenqiu Liu, Hong Fan, Tingting Shi, Xinyu Han, Chen Suo, Xingdong Chen, Tiejun Zhang
    European Journal of Gastroenterology & Hepatology.2023; 35(3): 294.     CrossRef
  • A novel non‐invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD
    Jian Wang, Rui Huang, Jiacheng Liu, Ruimin Lai, Yilin Liu, Chuanwu Zhu, Yuanwang Qiu, Zebao He, Shengxia Yin, Yuxin Chen, Xiaomin Yan, Weimao Ding, Qi Zheng, Jie Li, Chao Wu
    Journal of Viral Hepatitis.2023; 30(4): 287.     CrossRef
  • Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease
    You-Wen Tan, Jia-Min Wang, Xing-Bei Zhou
    World Journal of Hepatology.2023; 15(2): 237.     CrossRef
  • Impact of MAFLD on the complications after hepatectomy in patients with HBV-related hepatocellular carcinoma
    Ke-Gong Xiong, Tai-Shun Lin, Jin-Feng Kong, Qing-Biao Lin, Li-Fang Chen, Kun-Yu Ke
    Medicine.2023; 102(9): e33062.     CrossRef
  • Pyroptosis, Metabolism, and Oxidation in Tumorigenesis: Mechanisms and Therapeutic Implications
    Qi Cao, Jia-Bao Zhang, Di-Yang Sun, Jiang-Tao Fu, Wen-Bin Wu, Xiao-Fei Chen, Dong-Jie Li, Pei Wang
    Antioxidants & Redox Signaling.2023; 39(7-9): 512.     CrossRef
  • The hepatitis B virus promotes the progression of non-alcoholic fatty liver disease through incomplete autophagy
    Yang Wang, Jiaxi Li, Shanshan Wang, Yuheng Pang, Pengxiang Liu, Bangxiang Xie, Shuangshuang Dou, Tongwang Yang, Xiaoni Liu, Ying Shi, Dexi Chen
    Free Radical Biology and Medicine.2023; 204: 326.     CrossRef
  • Impact of prior HBV, HAV, and HEV infection on non‐alcoholic fatty liver disease
    Stephanos Vassilopoulos, Markos Kalligeros, Athanasios Vassilopoulos, Fadi Shehadeh, Gregorio Benitez, Matthew Kaczynski, Ingrid Lazaridou, Kittichai Promrat, Jack R. Wands, Eleftherios Mylonakis
    Journal of Viral Hepatitis.2023; 30(8): 685.     CrossRef
  • Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
    Byeong Geun Song, Sung Chul Choi, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Seung Woon Paik
    JHEP Reports.2023; 5(9): 100810.     CrossRef
  • Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis
    Yu Jun Wong, Vy H. Nguyen, Hwai-I Yang, Jie Li, Michael Huan Le, Wan-Jung Wu, Nicole Xinrong Han, Khi Yung Fong, Elizebeth Chen, Connie Wong, Fajuan Rui, Xiaoming Xu, Qi Xue, Xin Yu Hu, Wei Qiang Leow, George Boon-Bee Goh, Ramsey Cheung, Grace Wong, Vince
    Clinical and Molecular Hepatology.2023; 29(3): 705.     CrossRef
  • The Global Prevalence of Nonalcoholic Fatty Liver Disease and its Association With Cancers: Systematic Review and Meta-Analysis
    Nor Asiah Muhamad, Nur Hasnah Maamor, Fatin Norhasny Leman, Zuraifah Asrah Mohamad, Sophia Karen Bakon, Mohd Hatta Abdul Mutalip, Izzah Athirah Rosli, Tahir Aris, Nai Ming Lai, Muhammad Radzi Abu Hassan
    Interactive Journal of Medical Research.2023; 12: e40653.     CrossRef
  • Tenofovir alafenamide significantly increased serum lipid levels compared with entecavir therapy in chronic hepatitis B virus patients
    Rui-Min Lai, Shan Lin, Miao-Miao Wang, Na Li, Jia-Hui Zhou, Xiao-Yu Lin, Tian-Bin Chen, Yue-Yong Zhu, Qi Zheng
    World Journal of Hepatology.2023; 15(8): 964.     CrossRef
  • Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV–HIV Co-infected Adults
    Richard K. Sterling, Wendy C. King, Mandana Khalili, David E. Kleiner, Amanda S. Hinerman, Mark Sulkowski, Raymond T. Chung, Mamta K. Jain, M auricio Lisker-Melman, David K. Wong, Marc G. Ghany
    Digestive Diseases and Sciences.2022; 67(2): 676.     CrossRef
  • Should We Treat Immune Tolerant Chronic Hepatitis B? Lessons from Asia
    Madhumita Premkumar, Yogesh K. Chawla
    Journal of Clinical and Experimental Hepatology.2022; 12(1): 144.     CrossRef
  • Comparison of biochemical response during antiviral treatment in patients with chronic hepatitis B infection
    Si Ho Kim, Eun Ju Cho, Boo‐ok Jang, Kyunghan Lee, Jae Kyun Choi, Gwang Hyeon Choi, Jeong‐Hoon Lee, Su Jong Yu, Yoon Jun Kim, Yun Bin Lee, Jeong‐Hwan Yoon, Jin‐Wook Kim, Sook‐Hyang Jeong, Eun Sun Jang
    Liver International.2022; 42(2): 320.     CrossRef
  • Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver
    Mi Na Kim, Kyungdo Han, Juhwan Yoo, Seong Gyu Hwang, Sang Hoon Ahn
    Alimentary Pharmacology & Therapeutics.2022; 55(1): 97.     CrossRef
  • Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC
    Lei Liu, Si Xie, Yu-Xian Teng, Zhu-Jian Deng, Kang Chen, Hao-Tian Liu, Rong-Rui Huo, Xiu-Mei Liang, Ping-Ping Guo, Da-Long Yang, Liang Ma, Bang-De Xiang, Le-Qun Li, Jian-Hong Zhong
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Severe Hepatic Steatosis Is Associated With Low-Level Viremia and Advanced Fibrosis in Patients With Chronic Hepatitis B in North America
    Hin Hin Ko, Nishi H. Patel, Sarah Haylock-Jacobs, Karen Doucette, Mang M. Ma, Curtis Cooper, Erin Kelly, Magdy Elkhashab, Edward Tam, Robert Bailey, Alexander Wong, Gerald Minuk, Philip Wong, Scott K. Fung, Giada Sebastiani, Alnoor Ramji, Carla S. Coffin
    Gastro Hep Advances.2022; 1(1): 106.     CrossRef
  • MAFLD is Associated with the Risk of Liver Fibrosis and Inflammatory Activity in HBeAg-Negative CHB Patients
    Xiaoman Chen, Jing Zhou, Lili Wu, Xiang Zhu, Hong Deng
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 673.     CrossRef
  • Validation for models for tumor recurrence after liver transplantation in hepatectomy patients
    Sung Joon Kim, Jong Man Kim, Nam-Joon Yi, Gyu-Seong Choi, Kwang-Woong Lee, Kyung-Suk Suh, Jae-Won Joh
    Annals of Surgical Treatment and Research.2022; 102(3): 131.     CrossRef
  • A Novel Noninvasive Diagnostic Model of HBV-Related Inflammation in Chronic Hepatitis B Virus Infection Patients With Concurrent Nonalcoholic Fatty Liver Disease
    Xuemei Tao, Lin Chen, Youfei Zhao, Yonggang Liu, Ruifang Shi, Bei Jiang, Yuqiang Mi, Liang Xu
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Hepatitis B Core-Related Antigen Is Useful for Predicting Phase and Prognosis of Hepatitis B e Antigen-Positive Patients
    Han Ah Lee, Hyun Woong Lee, Younhee Park, Hyon-Suk Kim, Yeon Seok Seo
    Journal of Clinical Medicine.2022; 11(6): 1729.     CrossRef
  • MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
    Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, Mohammed Eslam, Jacob George, Takuji Torimura
    Clinical and Molecular Hepatology.2022; 28(2): 150.     CrossRef
  • Precision medicine in the era of potent antiviral therapy for chronic hepatitis B
    Eileen L. Yoon, Dae Won Jun
    Journal of Gastroenterology and Hepatology.2022; 37(7): 1191.     CrossRef
  • Metabolic Risk Factors Are Associated with the Disease Severity and Prognosis of Hepatitis B Virus-Related Acute on Chronic Liver Failure
    Lu Chen, Jinjin Dai, Qing Xie, Xiaolin Wang, Wei Cai
    Gut and Liver.2022; 16(3): 456.     CrossRef
  • Impact of NAFLD on the outcome of patients with chronic hepatitis B in Asia
    Ming Yang, Lai Wei
    Liver International.2022; 42(9): 1981.     CrossRef
  • Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
    Han Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim
    Clinical and Molecular Hepatology.2022; 28(3): 425.     CrossRef
  • Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease
    Han Ah Lee, Seung-seob Kim, Jin-Young Choi, Yeon Seok Seo, Beom Jin Park, Ki Choon Sim, Seung Up Kim
    Abdominal Radiology.2022; 47(11): 3733.     CrossRef
  • Clinical impact and mechanisms of hepatitis B virus infection concurrent with non-alcoholic fatty liver disease
    Xin Tong, Yu Song, Shengxia Yin, Jian Wang, Rui Huang, Chao Wu, Junping Shi, Jie Li
    Chinese Medical Journal.2022; 135(14): 1653.     CrossRef
  • Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name
    Cheng Han Ng, Daniel Q. Huang, Mindie H. Nguyen
    Clinical and Molecular Hepatology.2022; 28(4): 790.     CrossRef
  • Progress in understanding of association between metabolic associated fatty liver disease and viral infectious diseases
    Zhao-Chun Chi
    World Chinese Journal of Digestology.2022; 30(18): 783.     CrossRef
  • Interaction and Possible Mechanism between Non-Alcoholic Fatty Liver Disease and Chronic Hepatitis B
    博诗 陈
    Advances in Clinical Medicine.2022; 12(11): 10453.     CrossRef
  • Radiomics Analysis of Magnetic Resonance Proton Density Fat Fraction for the Diagnosis of Hepatic Steatosis in Patients With Suspected Non-Alcoholic Fatty Liver Disease
    Ki Choon Sim, Min Ju Kim, Yongwon Cho, Hyun Jin Kim, Beom Jin Park, Deuk Jae Sung, Na Yeon Han, Yeo Eun Han, Tae Hyung Kim, Yoo Jin Lee
    Journal of Korean Medical Science.2022;[Epub]     CrossRef
  • Clinical study of ganshuang granule combined with tenofovir in the treatment of chronic hepatitis B complicated with nonalcoholic fatty liver disease
    Changtian Su, Qin Yang
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • NAFLD and HBV interplay - related mechanisms underlying liver disease progression
    Evanthia Tourkochristou, Stelios F. Assimakopoulos, Konstantinos Thomopoulos, Markos Marangos, Christos Triantos
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Metabolic syndromes, hepatitis B virus (HBV), and hepatitis C virus as three factors involved in the development of hepatic steatosis: a systematic review and meta-analysis
    Masoud Keikha, Amirhossein Sahebkar, Tannaz Jamialahmadi, Mohsen Karbalaei
    Reviews and Research in Medical Microbiology.2022; 33(3): 139.     CrossRef
  • Secondary prevention of hepatitis B virus‐related hepatocellular carcinoma with current antiviral therapies
    Jonggi Choi, Young‐Suk Lim
    The Kaohsiung Journal of Medical Sciences.2021; 37(4): 262.     CrossRef
  • HRD1 attenuates the high uptake of [18F]FDG in hepatocellular carcinoma PET imaging
    Ai-Mei Li, Xia-Wen Lin, Jing-Tao Shen, Min Li, Qi-Huang Zheng, Zheng-Yang Zhou, Ming Shi
    Nuclear Medicine and Biology.2021; 96-97: 27.     CrossRef
  • The FIB-4 Index Is a Useful Predictor for the Development of Hepatocellular Carcinoma in Patients with Coexisting Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
    Minah Kim, Yeonju Lee, Jun Sik Yoon, Minjong Lee, So Shin Kye, Sun Woong Kim, Yuri Cho
    Cancers.2021; 13(10): 2301.     CrossRef
  • Association of Metabolic Risk Factors With Risks of Cancer and All‐Cause Mortality in Patients With Chronic Hepatitis B
    Yun Bin Lee, Hyemi Moon, Jeong‐Hoon Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Fabien Zoulim, Juneyoung Lee, Jung‐Hwan Yoon
    Hepatology.2021; 73(6): 2266.     CrossRef
  • Pyroptosis: mechanisms and diseases
    Pian Yu, Xu Zhang, Nian Liu, Ling Tang, Cong Peng, Xiang Chen
    Signal Transduction and Targeted Therapy.2021;[Epub]     CrossRef
  • Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B
    Laurens A. van Kleef, Hannah S.J. Choi, Willem P. Brouwer, Bettina E. Hansen, Keyur Patel, Robert A. de Man, Harry L.A. Janssen, Robert J. de Knegt, Milan J. Sonneveld
    JHEP Reports.2021; 3(5): 100350.     CrossRef
  • Systematic review with meta‐analysis: prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis B
    Qi Zheng, Biyao Zou, Yuankai Wu, Yeehui Yeo, Huizhen Wu, Christopher D Stave, Ramsey C. Cheung, Mindie H. Nguyen
    Alimentary Pharmacology & Therapeutics.2021; 54(9): 1100.     CrossRef
  • Association of central obesity with hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy
    Rong Fan, Junqi Niu, Hong Ma, Qing Xie, Jun Cheng, Huiying Rao, Xiaoguang Dou, Jianping Xie, Wei Zhao, Jie Peng, Zhiliang Gao, Hongbo Gao, Xinyue Chen, Jinjun Chen, Qiang Li, Hong Tang, Zhengang Zhang, Hong Ren, Mingliang Cheng, Xieer Liang, Chaonan Zhu,
    Alimentary Pharmacology & Therapeutics.2021; 54(3): 329.     CrossRef
  • Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy
    Joo Hyun Oh, Hye Won Lee, Dong Hyun Sinn, Jun Yong Park, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Wonseok Kang, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik
    Hepatology International.2021; 15(4): 892.     CrossRef
  • Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion
    Yi-Wen Shi, Rui-Xu Yang, Jian-Gao Fan
    World Journal of Gastroenterology.2021; 27(26): 3971.     CrossRef
  • The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
    Hye Won Lee, Hyun Woong Lee, Jae Seung Lee, Yun Ho Roh, Hyein Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    Journal of Hepatocellular Carcinoma.2021; Volume 8: 467.     CrossRef
  • REPLY:
    Yun Bin Lee, Juneyoung Lee
    Hepatology.2021; 74(2): 1135.     CrossRef
  • Reply
    Hye Won Lee, Beom Kyung Kim
    Clinical Gastroenterology and Hepatology.2020; 18(1): 264.     CrossRef
  • Magnetic resonance imaging of obesity and metabolic disorders: Summary from the 2019 ISMRM Workshop
    Houchun H. Hu, Rosa Tamara Branca, Diego Hernando, Dimitrios C. Karampinos, Jürgen Machann, Charles A. McKenzie, Holden H. Wu, Takeshi Yokoo, S. Sendhil Velan
    Magnetic Resonance in Medicine.2020; 83(5): 1565.     CrossRef
  • Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis
    Miao Fang, Min Yao, Jie Yang, Wen-Jie Zheng, Li Wang, Deng-Fu Yao
    World Journal of Gastrointestinal Oncology.2020; 12(1): 66.     CrossRef
  • Chronic hepatitis B and non‐alcoholic fatty liver disease: Conspirators or competitors?
    Jianbin Zhang, Shuangzhe Lin, Daixi Jiang, Mengting Li, Yuanwen Chen, Jun Li, Jiangao Fan
    Liver International.2020; 40(3): 496.     CrossRef
  • Earlier Alanine Aminotransferase Normalization During Antiviral Treatment Is Independently Associated With Lower Risk of Hepatocellular Carcinoma in Chronic Hepatitis B
    Jonggi Choi, Gi-Ae Kim, Seungbong Han, Young-Suk Lim
    American Journal of Gastroenterology.2020; 115(3): 406.     CrossRef
  • Approach to the patient with chronic hepatitis B and decompensated cirrhosis
    Mitchell L. Shiffman
    Liver International.2020; 40(S1): 22.     CrossRef
  • Presence of Hepatic Steatosis Does Not Increase the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Over Long Follow-Up
    Chong Teik Lim, George Boon Bee Goh, Huihua Li, Tony Kiat-Hon Lim, Wei Qiang Leow, Wei Keat Wan, Rafay Azhar, Wan Cheng Chow, Rajneesh Kumar
    Microbiology Insights.2020;[Epub]     CrossRef
  • Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
    Han Ah Lee, Yeon Seok Seo, Seung Up Kim
    Gastroenterology.2020; 158(8): 2310.     CrossRef
  • Radiologic Nonalcoholic Fatty Liver Disease Increases the Risk of Hepatocellular Carcinoma in Patients With Suppressed Chronic Hepatitis B
    Hyeki Cho, Young Chang, Jeong-Hoon Lee, Young Youn Cho, Joon Yeul Nam, Yun Bin Lee, Dong Ho Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jeong Min Lee, Jung-Hwan Yoon
    Journal of Clinical Gastroenterology.2020; 54(7): 633.     CrossRef
  • A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
    Hira Hanif, Muzammil M. Khan, Mukarram J. Ali, Pir A. Shah, Jinendra Satiya, Daryl T.Y. Lau, Aysha Aslam
    Microorganisms.2020; 8(10): 1526.     CrossRef
  • Letter: fatty liver disease could have been a confounding factor for phase change in patients with chronic hepatitis B in the immune‐tolerant phase—authors' reply
    Han Ah Lee, Seung Up Kim
    Alimentary Pharmacology & Therapeutics.2020; 52(6): 1094.     CrossRef
  • The Effects of Hepatic Steatosis on the Natural History of HBV Infection
    Idrees Suliman, Noha Abdelgelil, Farah Kassamali, Tarek I. Hassanein
    Clinics in Liver Disease.2019; 23(3): 433.     CrossRef
  • 13,088 View
  • 377 Download
  • 91 Web of Science
  • Crossref

Review

Viral hepatitis

Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade
Hyung Joon Yim, Seong Gyu Hwang
Clin Mol Hepatol 2013;19(3):195-209.
Published online September 30, 2013
DOI: https://doi.org/10.3350/cmh.2013.19.3.195

Although much advancement has been achieved in the treatment of chronic hepatitis B, antiviral resistance is still a challenging issue. Previous generation antiviral agents have already developed resistance in a number of patients, and it is still being used especially in resource limited countries. Once antiviral resistance occurs, it predisposes to subsequent resistance, resulting in multidrug resistance. Therefore, prevention of initial antiviral resistance is the most important strategy, and appropriate choice and modification of therapy would be the cornerstone in avoiding treatment failures. Until now, management of antiviral resistance has been evolving from sequential therapy to combination therapy. In the era of tenofovir, the paradigm shifts again, and we have to decide when to switch and when to combine on the basis of newly emerging clinical data. We expect future eradication of chronic hepatitis B virus infection by proper prevention and optimal management of antiviral resistance.

Citations

Citations to this article as recorded by  Crossref logo
  • Aqueous-based lignin extractions from birch, wheat, and oat exhibit broad antimicrobial activities
    Jun Liu, Marjo Haapakoski, Lotta-Riina Sundberg, Lari Vähäsalo, Pia Vento, Maiju Pöysti, Varpu Marjomäki
    International Journal of Biological Macromolecules.2025; 319: 145736.     CrossRef
  • Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 Update
    Paul Martin, Mindie H. Nguyen, Douglas T. Dieterich, Daryl T.-Y. Lau, Harry L.A. Janssen, Marion G. Peters, Ira M. Jacobson
    Clinical Gastroenterology and Hepatology.2022; 20(8): 1766.     CrossRef
  • Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers: A 35,000‐Korean outcome study
    Jihye Lim, Jung‐Bok Lee, Jihyun An, Gi‐Won Song, Kang Mo Kim, Han Chu Lee, Ju Hyun Shim
    Journal of Viral Hepatitis.2022; 29(9): 756.     CrossRef
  • How to Effectively Monitor Aging Patients with Chronic Hepatitis B: A Review
    Chan Keat Kang, Paul N Brennan, John F Dillon
    Clinical Interventions in Aging.2022; Volume 17: 1811.     CrossRef
  • Maintaining Antiviral Efficacy after Switching to Generic Entecavir 1 mg for Antiviral-resistant Chronic Hepatitis B
    Young Eun Ahn, Sang Jun Suh, Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim
    The Korean Journal of Gastroenterology.2021; 77(1): 22.     CrossRef
  • Companion and complementary diagnostics for infectious diseases
    Peter J. Dailey, Tarek Elbeik, Mark Holodniy
    Expert Review of Molecular Diagnostics.2020; 20(6): 619.     CrossRef
  • Tenofovir‐based combination therapy or monotherapy for multidrug‐resistant chronic hepatitis B: Long‐term data from a multicenter cohort study
    Hyung Joon Yim, Sang Jun Suh, Young Kul Jung, Seong Gyu Hwang, Yeon Seok Seo, Soon Ho Um, Sae Hwan Lee, Young Seok Kim, Jae Young Jang, In Hee Kim, Hyoung Su Kim, Ji Hoon Kim, Young Sun Lee, Eileen L. Yoon, Myeong Jun Song, Jun Yong Park
    Journal of Viral Hepatitis.2020; 27(12): 1306.     CrossRef
  • Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
    Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, Eileen L. Yoon, Hana Park, Jung Hyun Kwon, Dong Hyun Sinn, Sae Hwan Lee, Jeong-Hoon Lee, Hyun Woong Lee
    Clinical and Molecular Hepatology.2020; 26(4): 411.     CrossRef
  • KASL clinical practice guidelines for management of chronic hepatitis B

    Clinical and Molecular Hepatology.2019; 25(2): 93.     CrossRef
  • 2′‐Fluoro‐6′‐methylene carbocyclic adenosine and its phosphoramidate prodrug: A novel anti‐HBV agent, active against drug‐resistant HBV mutants
    Uma S. Singh, Varughese A. Mulamoottil, Chung K. Chu
    Medicinal Research Reviews.2018; 38(3): 977.     CrossRef
  • Direct Detection of Drug-Resistant Hepatitis B Virus in Serum Using a Dendron-Modified Microarray
    Doo Hyun Kim, Hong Seok Kang, Seong-Suk Hur, Seobo Sim, Sung Hyun Ahn, Yong Kwang Park, Eun-Sook Park, Ah Ram Lee, Soree Park, So Young Kwon, Jeong-Hoon Lee, Kyun-Hwan Kim
    Gut and Liver.2018; 12(3): 331.     CrossRef
  • The management of hepatitis B and hepatitis C in children
    Irini D. Batsis, Paul Wasuwanich, Wikrom W. Karnsakul
    Minerva Pediatrica.2018;[Epub]     CrossRef
  • Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study
    Eun Young Cho, Hyung Joon Yim, Young Kul Jung, Sang Jun Suh, Yeon Seok Seo, Ji Hoon Kim, Hong Soo Kim, Sae Hwan Lee, Sang Hoon Ahn, Jeong Il Lee, Sook-Hyang Jeong, Jin-Wook Kim, Jin-Woo Lee, In Hee Kim, Hyoung Su Kim, Sang Jong Park, Jeong Mi Lee, Seong G
    Gut and Liver.2017; 11(1): 129.     CrossRef
  • The development of hepatocarcinoma after long-term antivirus treatment of Chinese patients with chronic hepatitis B virus infection: Incidence, long-term outcomes and predictive factors
    Zhi-Qin Li, Chun-Ling Hu, Ping Yu, Xin-Yu Gu, Jia-Jia Zhang, Hua Li, Hong-Yu Zhang, Jun Lv, Yan-Min Liu, Qing-Lei Zeng, Jing-Ya Yan, Zu-Jiang Yu, Yi Zhang
    Clinics and Research in Hepatology and Gastroenterology.2017; 41(3): 311.     CrossRef
  • Aligning to the sample-specific reference sequence to optimize the accuracy of next-generation sequencing analysis for hepatitis B virus
    Wen-Chun Liu, Chih-Peng Lin, Chun-Pei Cheng, Cheng-Hsun Ho, Kuo-Lun Lan, Ji-Hong Cheng, Chia-Jui Yen, Pin-Nan Cheng, I-Chin Wu, I-Chen Li, Bill Chia-Han Chang, Vincent S. Tseng, Yen-Cheng Chiu, Ting-Tsung Chang
    Hepatology International.2016; 10(1): 147.     CrossRef
  • Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment
    Dorota Kozielewicz, Waldemar Halota, Magdalena Wietlicka-Piszcz
    Hepatology International.2016; 10(2): 302.     CrossRef
  • Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
    Hyung Joon Yim
    Clinical and Molecular Hepatology.2016; 22(2): 238.     CrossRef
  • Entecavir plus tenofovir combination therapy in patients with multidrug‐resistant chronic hepatitis B: results of a multicentre, prospective study
    Jun Yong Park, Chang Wook Kim, Si Hyun Bae, Kyu Sik Jung, Hee Yeon Kim, Seung Kew Yoon, Kwang‐Hyub Han, Sang Hoon Ahn
    Liver International.2016; 36(8): 1108.     CrossRef
  • Identification of UQCRB as an oxymatrine recognizing protein using a T7 phage display screen
    Yan-hui Sun, Xiao-yuan Zhang, Wei-qun Xie, Guang-jian Liu, Xi-xin He, Ya-li Huang, Guang-xian Zhang, Jian Wang, Zao-yuan Kuang, Ren Zhang
    Journal of Ethnopharmacology.2016; 193: 133.     CrossRef
  • Efficacy of telbivudine compared with entecavir in hepatitis B virus‐related cirrhosis: 2 year follow‐up data
    Hae Rim Kim, Hyung Joon Yim, Seonghee Kang, Sang Jun Suh, Seung Young Kim, Jong Jin Hyun, Ja Seol Koo, Ji Hoon Kim, Yeon Seok Seo, Jong Eun Yeon, Sang Woo Lee, Kwan Soo Byun, Soon Ho Um
    Liver International.2015; 35(3): 860.     CrossRef
  • A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update
    Paul Martin, Daryl T.-Y. Lau, Mindie H. Nguyen, Harry L.A. Janssen, Douglas T. Dieterich, Marion G. Peters, Ira M. Jacobson
    Clinical Gastroenterology and Hepatology.2015; 13(12): 2071.     CrossRef
  • Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance
    Sung Hyun Ahn, Doo Hyun Kim, Ah Ram Lee, Beom Kyung Kim, Yong Kwang Park, Eun-Sook Park, Sang Hoon Ahn, Gu-Choul Shin, Soree Park, Hong Seok Kang, Jin-Kyu Rhee, Sung-Il Yang, Youhoon Chong, Kyun-Hwan Kim, Jason Blackard
    PLOS ONE.2015; 10(8): e0136728.     CrossRef
  • Management of entecavir-resistant chronic hepatitis B with adefovir-based combination therapies
    Hyoung Su Kim
    World Journal of Gastroenterology.2015; 21(38): 10874.     CrossRef
  • Comparison of Lamivudine Plus Adefovir Therapy Versus Entecavir With or Without Adefovir Therapy for Adefovir-resistant Chronic Hepatitis B
    Seong Hee Kang, Hyung Joon Yim, Hae Rim Kim, Keunhee Kang, Sang Jun Suh, Hyun Jung Lee, Eileen L. Yoon, Ji Hoon Kim, Yeon Seok Seo, Jong Eun Yeon, Kwan Soo Byun
    Journal of Clinical Gastroenterology.2014; 48(10): 889.     CrossRef
  • Oral antiviral agents for treatment of chronic hepatitis B
    Soon Young Ko, Won Hyeok Choe
    Journal of the Korean Medical Association.2014; 57(1): 60.     CrossRef
  • 14,824 View
  • 74 Download
  • Crossref

Original Article

Viral hepatitis

Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study
Dae Won Jun, Byung Ik Kim, Yong Kyun Cho, Hong Ju Kim, Young Oh Kwon, Soo Young Park, Sang Young Han, Yang Hyun Baek, Yong Jin Jung, Hwi Young Kim, Won Kim, Jeong Heo, Hyun Young Woo, Seong Gyu Hwang, Kyu Sung Rim, Jong Young Choi, Si Hyun Bae, Young Sang Lee, Young Suck Lim, Jae Youn Cheong, Sung Won Cho, Byung Seok Lee, Seok Hyun Kim, Joo Hyun Sohn, Tae Yeob Kim, Yong Han Paik, Ja Kyung Kim, Kwan Sik Lee
Clin Mol Hepatol 2013;19(2):165-172.
Published online June 27, 2013
DOI: https://doi.org/10.3350/cmh.2013.19.2.165
Background/Aims

Carnitine and vitamin complex (Godex®) is widely used in patients with chronic liver disease who show elevated liver enzyme in South Korea. The purpose of this study is to identify the efficacy and safety of carnitine from entecavir combination therapy in Alanine aminotransferase (ALT) elevated Chronic Hepatitis B (CHB) patients.

Methods

130 treatment-naïve patients with CHB were enrolled from 13 sites. The patients were randomly selected to the entecavir and the complex of entecavir and carnitine. The primary endpoint of the study is ALT normalization level after 12 months.

Results

Among the 130 patients, 119 patients completed the study treatment. The ALT normalization at 3 months was 58.9% for the monotherapy and 95.2% for the combination therapy (P<0.0001). ALT normalization rate at 12 months was 85.7% for the monotherapy and 100% for the combination group (P=0.0019). The rate of less than HBV DNA 300 copies/mL at 12 months was not statistically significant (P=0.5318) 75.9% for the monotherapy, 70.7% for the combination and it was. Quantification of HBsAg level was not different from the monotherapy to combination at 12 months. Changes of ELISPOT value to evaluate the INF-γ secretion by HBsAg showed the increasing trend of combination therapy compare to mono-treatment.

Conclusions

ALT normalization rate was higher in carnitine complex combination group than entecavir group in CHB. Combination group was faster than entecavir mono-treatment group on ALT normalization rate. HBV DNA normalization rate and the serum HBV-DNA level were not changed by carnitine complex treatment.

Citations

Citations to this article as recorded by  Crossref logo
  • Developments in small molecule antiviral drugs against hepatitis B and C viruses: FDA approved therapies and new drugs in clinical trials
    Palak K. Parikh, Nisha H. Parikh, Mahalakshmi B, Ketan M. Ranch, Sai H.S. Boddu, Jayachandra Babu R, Amit K. Tiwari
    Arabian Journal of Chemistry.2023; 16(8): 105013.     CrossRef
  • Besifovir therapy improves hepatic histology and reduces covalently closed circular DNA in chronic hepatitis B patients
    Hyung Joon Yim, Won Kim, Sang Hoon Ahn, Young Kul Jung, Soon Ho Um, Joo Hyun Sohn, Jae Young Jang, Dong Joon Kim, Eun‐Sook Park, So‐Young Jin, Kyun‐Hwan Kim
    Journal of Gastroenterology and Hepatology.2022; 37(2): 378.     CrossRef
  • Hepatocyte-Derived L-Carnitine Restricts Hepatitis B Surface Antigen Loss Through an Immunosuppressive Effect on Germinal Center–Related Immune Cells
    Shuqin Gu, Weibin Wang, Guofu Ye, Chengcong Chen, Yang Zhou, Ling Guo, Shihong Zhong, Xiaoyi Li, Xin Fu, Chunhua Wen, Libo Tang, Jian Sun, Jinlin Hou, Yongyin Li
    The Journal of Infectious Diseases.2022; 225(11): 1955.     CrossRef
  • Effect of L-carnitine on quality of life in covert hepatic encephalopathy: a randomized, double-blind, placebo-controlled study
    Eileen L. Yoon, Sang Bong Ahn, Dae Won Jun, Yong Kyun Cho, Do Seon Song, Jae Yoon Jeong, Hee Yeon Kim, Young Kul Jung, Myeong Jun Song, Sung Eun Kim, Hyoung Su Kim, Soung Won Jeong, Sang Gyune Kim, Tae Hee Lee
    The Korean Journal of Internal Medicine.2022; 37(4): 757.     CrossRef
  • Impact of l-Carnitine Supplementation on Liver Enzyme Normalization in Patients with Chronic Liver Disease: A Meta-Analysis of Randomized Trials
    Hyunwoo Oh, Chan Hyuk Park, Dae Won Jun
    Journal of Personalized Medicine.2022; 12(7): 1053.     CrossRef
  • Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
    Han Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim
    Clinical and Molecular Hepatology.2022; 28(3): 425.     CrossRef
  • Prolonged Use of Carnitine-Orotate Complex (Godex®) Is Associated with Improved Mortality: A Nationwide Cohort Study
    Kye-Yeung Park, Sangmo Hong, Kyung-Soo Kim, Kyungdo Han, Cheol-Young Park
    Journal of Personalized Medicine.2022; 12(12): 1970.     CrossRef
  • Role of Carnitine in Non-alcoholic Fatty Liver Disease and Other Related Diseases: An Update
    Na Li, Hui Zhao
    Frontiers in Medicine.2021;[Epub]     CrossRef
  • High L-Carnitine Levels Impede Viral Control in Chronic Hepatitis B Virus Infection
    Shuqin Gu, Xin Fu, Guofu Ye, Chengcong Chen, Xiaoyi Li, Shihong Zhong, Libo Tang, Haitao Chen, Deke Jiang, Jinlin Hou, Yongyin Li
    Frontiers in Immunology.2021;[Epub]     CrossRef
  • Besifovir dipivoxil maleate: a novel antiviral agent with low toxicity and high genetic barriers for chronic hepatitis B
    Jeong Eun Song, Jun Yong Park
    Expert Opinion on Pharmacotherapy.2021; 22(18): 2427.     CrossRef
  • Carnitine Orotate Complex Ameliorates Insulin Resistance and Hepatic Steatosis Through Carnitine Acetyltransferase Pathway
    Jung-Hee Hong, Moon-Kyu Lee
    Diabetes & Metabolism Journal.2021; 45(6): 933.     CrossRef
  • Does l-carnitine supplementation affect serum levels of enzymes mainly produced by liver? A systematic review and meta-analysis of randomized controlled clinical trials
    Farzaneh Pirmadah, Nahid Ramezani-Jolfaie, Mohammad Mohammadi, Nasir Talenezhad, Cain C. T. Clark, Amin Salehi-Abargouei
    European Journal of Nutrition.2020; 59(5): 1767.     CrossRef
  • The protective role of l-carnitine against 1st- and 2nd-generation antihistamine-induced liver injury in mice
    Rania A. Abdel-Emam, Esraa A. Ahmed, Marwa F. Ali
    Comparative Clinical Pathology.2020; 29(1): 213.     CrossRef
  • Influence of Besifovir Dipivoxil Maleate Combined with L-Carnitine on Hepatic Steatosis in Patients with Chronic Hepatitis B
    Yeon Woo Jung, Moonhyun Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
    Journal of Korean Medical Science.2020;[Epub]     CrossRef
  • Effects of carnitine supplementation on liver aminotransferase enzymes: A systematic review and meta-analysis of randomized controlled clinical trials
    Esmaeil Yousefi Rad, Elham Eslampour, Ebrahim Falahi, Mahnaz Mardani, Azita Hekmatdoost, Omid Asbaghi, Somayeh Saboori
    Indian Journal of Gastroenterology.2019; 38(6): 470.     CrossRef
  • L‐Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis
    Masatsugu Ohara, Koji Ogawa, Goki Suda, Megumi Kimura, Osamu Maehara, Tomoe Shimazaki, Kazuharu Suzuki, Akihisa Nakamura, Machiko Umemura, Takaaki Izumi, Naoki Kawagishi, Masato Nakai, Takuya Sho, Mitsuteru Natsuizaka, Kenichi Morikawa, Shunsuke Ohnishi,
    Hepatology Communications.2018; 2(8): 910.     CrossRef
  • Levocarnitine for asparaginase-induced hepatic injury: a multi-institutional case series and review of the literature
    Rachael R. Schulte, Manasi V. Madiwale, Allyson Flower, Jessica Hochberg, Michael J. Burke, Jennifer L. McNeer, Adam DuVall, Archie Bleyer
    Leukemia & Lymphoma.2018; 59(10): 2360.     CrossRef
  • Anti-adipogenic and antiviral effects ofl-carnitine on hepatitis C virus infection
    Yoko Tsukuda, Goki Suda, Seiji Tsunematsu, Jun Ito, Fumiyuki Sato, Katsumi Terashita, Masato Nakai, Takuya Sho, Osamu Maehara, Tomoe Shimazaki, Megumi Kimura, Kenichi Morikawa, Mitsuteru Natsuizaka, Koji Ogawa, Shunsuke Ohnishi, Makoto Chuma, Naoya Sakamo
    Journal of Medical Virology.2017; 89(5): 857.     CrossRef
  • Glycyrrhetic acid, but not glycyrrhizic acid, strengthened entecavir activity by promoting its subcellular distribution in the liver via efflux inhibition
    Qianying Chen, Hongzhu Chen, Wenjie Wang, Jiali Liu, Wenyue Liu, Ping Ni, Guowei Sang, Guangji Wang, Fang Zhou, Jingwei Zhang
    European Journal of Pharmaceutical Sciences.2017; 106: 313.     CrossRef
  • A Case of Therapeutic Laser for Suggested Drug Induced Liver Injury Patient during Treatment of Korean Medicine
    Kyeong-Tae Lim, Byung-Cheul Shin, Eui-Hyoung Hwang, In Heo, Byung-Jun Kim, Kwang-Ho Heo
    Journal of Korean Medicine Rehabilitation.2016; 26(3): 183.     CrossRef
  • Quantitative NTCP pharmacophore and lack of association between DILI and NTCP Inhibition
    Zhongqi Dong, Sean Ekins, James E. Polli
    European Journal of Pharmaceutical Sciences.2015; 66: 1.     CrossRef
  • Comparison on the Efficacy and Safety of Biphenyl Dimethyl Dicarboxylate and Ursodeoxycholic Acid in Patients with Abnormal Alanine Aminotransferase: Multicenter, Double-blinded, Randomized, Active-controlled Clinical Trial
    Sae Hwan Lee, Gab Jin Cheon, Hong Soo Kim, Young Don Kim, Sang Gyune Kim, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim
    The Korean Journal of Gastroenterology.2014; 64(1): 31.     CrossRef
  • 13,880 View
  • 177 Download
  • Crossref
Review
Revision and update on clinical practice guideline for liver cirrhosis
Ki Tae Suk, Soon Koo Baik, Jung Hwan Yoon, Jae Youn Cheong, Yong Han Paik, Chang Hyeong Lee, Young Seok Kim, Jin Woo Lee, Dong Joon Kim, Sung Won Cho, Seong Gyu Hwang, Joo Hyun Sohn, Moon Young Kim, Young Bae Kim, Jae Geun Kim, Yong Kyun Cho, Moon Seok Choi, Hyung Joon Kim, Hyun Woong Lee, Seung Up Kim, Ja Kyung Kim, Jin Young Choi, Dae Won Jun, Won Young Tak, Byung Seok Lee, Byoung Kuk Jang, Woo Jin Chung, Hong Soo Kim, Jae Young Jang, Soung Won Jeong, Sang Gyune Kim, Oh Sang Kwon, Young Kul Jung, Won Hyeok Choe, June Sung Lee, In Hee Kim, Jae Jun Shim, Gab Jin Cheon, Si Hyun Bae, Yeon Seok Seo, Dae Hee Choi, Se Jin Jang
Korean J Hepatol 2012;18(1):1-21.
Published online March 22, 2012
DOI: https://doi.org/10.3350/kjhep.2012.18.1.1

Citations

Citations to this article as recorded by  Crossref logo
  • GLOBE Score and UK‐PBC Risk Score Predict Long‐Term Clinical Outcomes of Patients With Primary Biliary Cholangitis and Receiving Ursodeoxycholic Acid and Fenofibrate
    Shu Xiang Li, Bu Er Li, Min Li, Sha Chen, Ting Ting Lyu, Qian Yi Wang, Xiao Ming Wang, Yu Wang, Hong Ma, Xiao Juan Ou, Yuan Yuan Kong, Xin Yan Zhao, Hong You, Wei Jia Duan, Ji Dong Jia
    Journal of Digestive Diseases.2025; 26(5-6): 250.     CrossRef
  • Enhanced Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma Using Age-male-albumin-bilirubin-platelet (aMAP) and Liver Stiffness Assessed by Vibration-controlled Transient Elastography
    Hye Yeon Chon, Hyung Joon Yim, Seok-Jae Heo, Su Jong Yu, Ja Kyung Kim, Sang Hoon Ahn, Grace Lai-Hung Wong, Jimmy Che-To Lai, Terry Cheuk-Fung Yip, Sang Gyune Kim, Yeon Seok Seo, Seung Up Kim
    Clinical Gastroenterology and Hepatology.2025;[Epub]     CrossRef
  • MetaLAB‐HOI: Template standardization of health outcomes enable massive and accurate detection of adverse drug reactions from electronic health records
    Suehyun Lee, Hyunah Shin, Seon Choe, Min‐Gyu Kang, Sae‐Hoon Kim, Dong Yoon Kang, Ju Han Kim
    Pharmacoepidemiology and Drug Safety.2024;[Epub]     CrossRef
  • Add-on immunosuppressive therapy may benefit selected patients with primary biliary cholangitis and autoimmune phenomena
    Mengqi Li, Sha Chen, Shuxiang Li, Tingting Lv, Buer Li, Shan Shan, Min Li, Na Zeng, Qianyi Wang, Yuanyuan Kong, Hong Ma, Xinyan Zhao, Xiaojuan Ou, Hong You, Weijia Duan, Jidong Jia
    Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
  • Establishment and evaluation of an early prediction model of hepatorenal syndrome in patients with decompensated hepatitis B cirrhosis
    Shouhao Wang, Zhewen Zhou, Chengan Xu, Hanzhu Chen, Wenya Ren, Xingdi Yang, Qiaoqiao Yin, Wei Zheng, Hongying Pan
    BMC Gastroenterology.2023;[Epub]     CrossRef
  • Initial treatment response and short-term mortality of spontaneous bacterial peritonitis in cirrhotic patients with hepatocellular carcinoma
    Chang Hun Lee, Hye Jin Kang, Song Yi Yu, Seung Young Seo, Seong Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, In Hee Kim
    Scientific Reports.2023;[Epub]     CrossRef
  • The Wnt/β-catenin signaling pathway plays a role in drug-induced liver injury by regulating cytochrome P450 2E1 expression
    Yoo-Sub Shin, Da-Bin Hwang, Dong-Hoon Won, Shin-Young Kim, Changuk Kim, Jun Won Park, Young Jeon, Jun-Won Yun
    Toxicological Research.2023; 39(3): 443.     CrossRef
  • Prognosis of Patients with Chronic Hepatitis C Genotype 1b Infection Treated Using Daclatasvir/Asunaprevir after Sustained Virologic Response: A 6-Year Multicenter Prospective Observational Study
    Jae-Hyun Yoon, Sung-Eun Kim, Su-Hyeon Cho, Gi-Ae Kim, Yewan Park, Ji-Won Park, Seong-Hee Kang, Young-Sun Lee, Jeong-Han Kim
    Medicina.2023; 59(8): 1436.     CrossRef
  • Concomitant gallstone disease was not associated with long‐term outcomes in ursodeoxycholic acid‐treated patients with primary biliary cholangitis
    Sha Chen, Meng Qi Li, Bu Er Li, Ting Ting Lv, Shu Xiang Li, Shan Shan, Min Li, Yuan Yuan Kong, Dong Zhang, Hong Ma, Xiao Juan Ou, Hong You, Wei Jia Duan, Ji Dong Jia
    Journal of Digestive Diseases.2023; 24(6-7): 419.     CrossRef
  • Reciprocal alterations in circulating and hepatic gamma–delta T cells in patients with primary biliary cholangitis
    Sha Chen, Tingting Lv, Guangyong Sun, Shuxiang Li, Weijia Duan, Chunpan Zhang, Hua Jin, Dan Tian, Mingyang Li, Shan Shan, Hong Ma, Xiaojuan Ou, Hong You, Dong Zhang, Jidong Jia
    Hepatology International.2022; 16(1): 195.     CrossRef
  • KASL clinical practice guidelines for management of chronic hepatitis B

    Clinical and Molecular Hepatology.2022; 28(2): 276.     CrossRef
  • Platelet-to-White Blood Cell Ratio Is Associated with Adverse Outcomes in Cirrhotic Patients with Acute Deterioration
    Jung Hee Kim, Sung-Eun Kim, Do-Seon Song, Hee-Yeon Kim, Eileen Yoon, Tae-Hyung Kim, Young-Kul Jung, Ki Tae Suk, Baek-Gyu Jun, Hyung-Joon Yim, Jung-Hyun Kwon, Sung-Won Lee, Seong-Hee Kang, Moon-Young Kim, Soung-Won Jeong, Jae-Young Jang, Jeong-Ju Yoo, Sang
    Journal of Clinical Medicine.2022; 11(9): 2463.     CrossRef
  • Concomitant extrahepatic autoimmune diseases do not compromise the long-term outcomes of primary biliary cholangitis
    Sha Chen, Meng-Qi Li, Wei-Jia Duan, Bu-Er Li, Shu-Xiang Li, Ting-Ting Lv, Lin Ma, Ji-Dong Jia
    Hepatobiliary & Pancreatic Diseases International.2022; 21(6): 577.     CrossRef
  • Expression Patterns of Tumor Markers in Liver Transplant Recipients Showing Complete Pathological Response of Hepatocellular Carcinoma
    Min-Jae Kim, Woo-Hyoung Kang, Shin Hwang, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park
    Journal of Clinical Medicine.2022; 11(19): 5897.     CrossRef
  • First experience of liver transplantation for HIV-positive patients in Russia
    M. S. Novruzbekov, V. A. Gulyaev, A. I. Mazus, E. V. Ivannikov, M. S. Yadrikhinskaya, K. N. Lutsyk, O. D. Olisov, R. B. Akhmetshin, K. M. Magomedov, B. I. Kazymov, A. R. Akhmedov, K. F. Alekberov, B. I. Yaremin
    Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH).2022; 12(6): 139.     CrossRef
  • Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B
    Hye Yeon Chon, Jae Seung Lee, Hye Won Lee, Ho Soo Chun, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
    Hepatology Research.2021; 51(4): 406.     CrossRef
  • Diagnostic usefulness of the spot urine sodium/potassium ratio in cirrhotic patients with ascites
    Jin Wook Lee, Jae Seok Hwang, Woo Jin Chung, Heon Ju Lee, Jung Gil Park, Chang Hyeong Lee, Byung Seok Kim, Jeong Eun Song, Young Oh Kweon, Won Young Tak, Soo Young Park, Se Young Jang, Jeong Ill Suh, Byoung Kuk Jang, Bhagwan Dass
    PLOS ONE.2021; 16(6): e0253886.     CrossRef
  • Effectiveness and safety of elbasvir/grazoprevir in Korean patients with hepatitis C virus infection: a nationwide real-world study
    Eun Sun Jang, Kyung-Ah Kim, Young Seok Kim, In Hee Kim, Byung Seok Lee, Youn Jae Lee, Woo Jin Chung, Sook-Hyang Jeong
    The Korean Journal of Internal Medicine.2021; 36(Suppl 1): S1.     CrossRef
  • Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma
    Han Ah Lee, Young-Sun Lee, Beom Kyung Kim, Young Kul Jung, Seung Up Kim, Jun Yong Park, Ji Hoon Kim, Hyunggin An, Do Young Kim, Hyung Joon Yim, Sang Hoon Ahn, Jong Eun Yeon, Kwan Soo Byun, Kwang-Hyub Han, Soon Ho Um, Yeon Seok Seo
    Gut and Liver.2021; 15(3): 420.     CrossRef
  • Guidelines for Prevention and Treatment of Chronic Hepatitis B
    Guiqiang Wang, Zhongping Duan
    Journal of Clinical and Translational Hepatology.2021; 000(000): 000.     CrossRef
  • The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
    Hye Won Lee, Hyun Woong Lee, Jae Seung Lee, Yun Ho Roh, Hyein Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    Journal of Hepatocellular Carcinoma.2021; Volume 8: 467.     CrossRef
  • Diagnosis and Management of Esophageal and Gastric Variceal Bleeding: Focused on 2019 KASL Clinical Practice Guidelines for Liver Cirrhosis
    Min Kyung Park, Yun Bin Lee
    The Korean Journal of Gastroenterology.2021; 78(3): 152.     CrossRef
  • KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications

    Clinical and Molecular Hepatology.2020; 26(2): 83.     CrossRef
  • Ultrasonographic morphological diagnosis of chronic liver disease: 2-dimensional shear wave elastography as an add-on test
    Young Seo Cho, Woo Kyoung Jeong, Yongsoo Kim
    Ultrasonography.2020; 39(3): 272.     CrossRef
  • Toward Quantitative and Operator-independent Quasi-static Ultrasound Elastography: An Ex Vivo Feasibility Study
    Sathiyamoorthy Selladurai, Abhilash Verma, Arun K. Thittai
    Ultrasonic Imaging.2020; 42(4-5): 179.     CrossRef
  • A Predictive Model Using N-Glycan Biosignatures for Clinical Diagnosis of Early Hepatocellular Carcinoma Related to Hepatitis B Virus
    Min Cong, Xiaojuan Ou, Jian Huang, Jiang Long, Tong Li, Xueen Liu, Yanhong Wang, Xiaoning Wu, Jialing Zhou, Yameng Sun, Qinghua Shang, Guofeng Chen, Hui Ma, Wen Xie, Hongxin Piao, Yongping Yang, Zhiliang Gao, Xiaoyuan Xu, Zongnan Tan, Chitty Chen, Na Zeng
    OMICS: A Journal of Integrative Biology.2020; 24(7): 415.     CrossRef
  • Serum small extracellular vesicle‐derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma
    Soon Sun Kim, Geum Ok Baek, Hye Ri Ahn, Suna Sung, Chul Won Seo, Hyo Jung Cho, Suk Woo Nam, Jae Youn Cheong, Jung Woo Eun
    Molecular Oncology.2020; 14(10): 2646.     CrossRef
  • Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding
    Jongbeom Shin, Jung Hwan Yu, Young-Joo Jin, Hyung Joon Yim, Young Kul Jung, Jin Mo Yang, Do Seon Song, Young Seok Kim, Sang Gyune Kim, Dong Joon Kim, Ki Tae Suk, Eileen L. Yoon, Sang Soo Lee, Chang Wook Kim, Hee Yeon Kim, Jae Young Jang, Soung Won Jeong
    Clinical and Molecular Hepatology.2020; 26(4): 540.     CrossRef
  • Managing liver cirrhotic complications: Overview of esophageal and gastric varices
    Cosmas Rinaldi Adithya Lesmana, Monica Raharjo, Rino A. Gani
    Clinical and Molecular Hepatology.2020; 26(4): 444.     CrossRef
  • Real-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin Dose
    Eun Sun Jang, Kyung-Ah Kim, Young Seok Kim, In Hee Kim, Byung Seok Lee, Youn Jae Lee, Woo Jin Chung, Sook-Hyang Jeong
    Gut and Liver.2020; 14(6): 775.     CrossRef
  • The changing epidemiology of liver diseases in the Asia–Pacific region
    Martin C. S. Wong, Jason L. W. Huang, Jacob George, Junjie Huang, Colette Leung, Mohammed Eslam, Henry L. Y. Chan, Siew C. Ng
    Nature Reviews Gastroenterology & Hepatology.2019; 16(1): 57.     CrossRef
  • Fibrosis‐matched outcomes between chronic hepatitis B patients with drug‐induced virological response and inactive carriers
    Hye Soo Kim, Oidov Baatarkhuu, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kijun Song, Kwang‐Hyub Han, Beom Kyung Kim, Seung Up Kim
    Liver International.2019; 39(1): 81.     CrossRef
  • Towards quantitative quasi-static ultrasound elastography using a reference layer for liver imaging application: A preliminary assessment
    Sathiyamoorthy Selladurai, Arun K. Thittai
    Ultrasonics.2019; 93: 7.     CrossRef
  • Prognosis of 732 ursodeoxycholic acid‐treated patients with primary biliary cholangitis: A single center follow‐up study from China
    Sha Chen, Weijia Duan, Min Li, Shuxiang Li, Tingting Lv, Qiuju Tian, Qianyi Wang, Xiaoning Wu, Xinyan Zhao, Xiaoming Wang, Yu Wang, Yuanyuan Kong, Hong Ma, Xiaojuan Ou, Hong You, Jidong Jia
    Journal of Gastroenterology and Hepatology.2019; 34(7): 1236.     CrossRef
  • Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model
    Tatsuro Nishimura, Taro Takami, Ryo Sasaki, Yuki Aibe, Takashi Matsuda, Koichi Fujisawa, Toshihiko Matsumoto, Naoki Yamamoto, Kenji Tani, Yasuho Taura, Isao Sakaida, Matias A Avila
    PLOS ONE.2019; 14(1): e0210588.     CrossRef
  • Small Hepatocellular Carcinoma With Low Tumor Marker Expression Benefits More From Anatomical Resection Than Tumors With Aggressive Biology
    Dong-Hwan Jung, Shin Hwang, Young-Joo Lee, Ki-Hun Kim, Gi-Won Song, Chul-Soo Ahn, Deok-Bog Moon, Sung-Gyu Lee
    Annals of Surgery.2019; 269(3): 511.     CrossRef
  • Response-Related Factors of Bone Marrow-Derived Mesenchymal Stem Cells Transplantation in Patients with Alcoholic Cirrhosis
    Haripriya Gupta, Gi Soo Youn, Sang Hak Han, Min Jea Shin, Sang Jun Yoon, Dae Hee Han, Na Young Lee, Dong Joon Kim, Soon Koo Baik, Ki Tae Suk
    Journal of Clinical Medicine.2019; 8(6): 862.     CrossRef
  • KASL clinical practice guidelines for management of chronic hepatitis B

    Clinical and Molecular Hepatology.2019; 25(2): 93.     CrossRef
  • Contrast-enhanced US with Perfluorobutane for Hepatocellular Carcinoma Surveillance: A Multicenter Diagnostic Trial (SCAN)
    Ji Hoon Park, Mi-Suk Park, So Jung Lee, Woo Kyoung Jeong, Jae Young Lee, Min Jung Park, Sung Soo Lee, Kyunghwa Han, Chung Mo Nam, Seong Ho Park, Kyoung Ho Lee
    Radiology.2019; 292(3): 638.     CrossRef
  • Current approaches to the management of patients with cirrhotic ascites
    Dmitry Victorovich Garbuzenko, Nikolay Olegovich Arefyev
    World Journal of Gastroenterology.2019; 25(28): 3738.     CrossRef
  • The New Cutoff Value of the Hepatic Venous Pressure Gradient on Predicting Long-Term Survival in Cirrhotic Patients
    Tae Yeob Kim, Ki Tae Suk, Soung Won Jeong, Tom Ryu, Dong Joon Kim, Soon Koo Baik, Joo Hyun Sohn, Woo Kyoung Jeong, Eunhee Choi, Jae Young Jang, Moon Young Kim
    Journal of Korean Medical Science.2019;[Epub]     CrossRef
  • Real‐life effectiveness and safety of the daclatasvir/asunaprevir combination therapy for genotype 1b chronic hepatitis C patients: An emphasis on the pretreatment NS5A resistance‐associated substitution test
    Eun Sun Jang, Kyung‐Ah Kim, Young Seok Kim, In Hee Kim, Byung Seok Lee, Youn Jae Lee, Woo Jin Chung, Sook‐Hyang Jeong
    Journal of Medical Virology.2019; 91(12): 2158.     CrossRef
  • Natural History and Treatment Indications of Chronic Hepatitis B
    Dong Hyun Sinn
    The Korean Journal of Gastroenterology.2019; 74(5): 245.     CrossRef
  • Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B
    Mi Young Jeon, Hye Won Lee, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang‐Hyub Han, Sang Hoon Ahn
    Liver International.2018; 38(4): 676.     CrossRef
  • Impact of Bacterial Translocation on Hepatopulmonary Syndrome: A Prospective Observational Study
    Ki Tae Suk, Moon Young Kim, Soung Won Jeong, Jae Young Jang, Yoon Ok Jang, Soon Koo Baik
    Digestive Diseases and Sciences.2018; 63(1): 248.     CrossRef
  • Utility and Limitations of Glycated Hemoglobin (HbA1c) in Patients with Liver Cirrhosis as Compared with Oral Glucose Tolerance Test for Diagnosis of Diabetes
    Tejasav Sehrawat, Anuraag Jindal, Paaras Kohli, Amit Thour, Jasbinder Kaur, Atul Sachdev, Yashdeep Gupta
    Diabetes Therapy.2018; 9(1): 243.     CrossRef
  • Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy
    Joohwan Bae, Dong Hyun Sinn, Wonseok Kang, Geum‐Youn Gwak, Moon Seok Choi, Yong‐Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
    Liver International.2018; 38(8): 1442.     CrossRef
  • Efficacy and safety of fenofibrate add-on therapy for patients with primary biliary cholangitis and a suboptimal response to UDCA
    Weijia Duan, Xiaojuan Ou, Xiaoming Wang, Yu Wang, Xinyan Zhao, Qianyi Wang, Xiaoning Wu, Wei Zhang, Hong Ma, Hong You, Jidong Jia
    Revista Española de Enfermedades Digestivas.2018;[Epub]     CrossRef
  • Factors Associated with Health-Related Quality of Life in Korean Patients with Chronic Hepatitis C Infection Using the SF-36 and EQ-5D
    Eun Sun Jang, Young Seok Kim, Kyung-Ah Kim, Youn Jae Lee, Woo Jin Chung, In Hee Kim, Byung Seok Lee, Sook-Hyang Jeong
    Gut and Liver.2018; 12(4): 440.     CrossRef
  • Accumulation of citrullinated glial fibrillary acidic protein in a mouse model of bile duct ligation-induced hepatic fibrosis
    Sung-Eun Kim, Ji Won Park, Mo-Jong Kim, Byungki Jang, Yong-Chul Jeon, Hee-Jun Kim, Akihito Ishigami, Hyoung Su Kim, Ki Tae Suk, Dong Joon Kim, Choong Kee Park, Eun-Kyoung Choi, Myoung-Kuk Jang, Leo A. van Grunsven
    PLOS ONE.2018; 13(8): e0201744.     CrossRef
  • KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications

    Clinical and Molecular Hepatology.2018; 24(3): 230.     CrossRef
  • 2017 Korean Association for the Study of the Liver (KASL) Clinical Practice Guidelines for Ascites and Related Complications: What Has Been Changed from the 2011 KASL Clinical Practice Guidelines?
    Yeon Seok Seo
    The Korean Journal of Gastroenterology.2018; 72(4): 179.     CrossRef
  • Iron metabolism disorders in patients with hepatitis B-related liver diseases
    Yan-Hang Gao, Jing-Yun Wang, Pei-Yan Liu, Jing Sun, Xiao-Mei Wang, Rui-Hong Wu, Xiu-Ting He, Zheng-Kun Tu, Chun-Guang Wang, Hong-Qin Xu, Jun-Qi Niu
    World Journal of Clinical Cases.2018; 6(13): 600.     CrossRef
  • Investigation on outcomes and bacterial distributions of liver cirrhosis patients with gram-negative bacterial bloodstream infection
    Yangxin Xie, Bo Tu, Xin Zhang, Jingfeng Bi, Lei Shi, Peng Zhao, Weiwei Chen, Suxia Liu, Dongping Xu, Enqiang Qin
    Oncotarget.2018; 9(3): 3980.     CrossRef
  • Alcoholic Liver Disease Is Associated with an Increased Risk of Gastric Cancer
    Tae Hoon Ha, Byeong Gwan Kim, Donghyong Jeong, Sohee Oh, Won Kim, Yong Jin Jung, Dong Won Ahn, Ji Bong Jeong, Ji Won Kim, Kook Lae Lee, Seong-Joon Koh
    Digestive Diseases and Sciences.2017; 62(1): 273.     CrossRef
  • Comparison of clinical characteristics and outcomes of spontaneous bacterial peritonitis and culture negative neutrocytic ascites
    Sun Hee Na, Eun Jung Kim, Eun Young Nam, Kyoung-Ho Song, Pyoeng Gyun Choe, Wan Beom Park, Ji Hwan Bang, Eu Suk Kim, Sang Won Park, Hong Bin Kim, Myoung-don Oh, Nam Joong Kim
    Scandinavian Journal of Gastroenterology.2017; 52(2): 199.     CrossRef
  • Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis
    Eui Joo Kim, Jong Eun Yeon, Oh Sang Kwon, Heon Nam Lee, Seung Kak Shin, Seong Hee Kang, Kwan Soo Byun, Jeong Han Kim, So Young Kwon, Sang Jun Suh, Hyung Joon Yim, Yun Soo Kim, Ju Hyun Kim
    Digestive Diseases and Sciences.2017; 62(3): 808.     CrossRef
  • Clinical Features of Spontaneous Bacterial Peritonitis: A 10-year Experience from a Single Center
    Ha Young Na, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Byung-chul Yoo
    The Korean Journal of Gastroenterology.2017; 69(2): 129.     CrossRef
  • Do We Need to Change the Treatment Strategy for Spontaneous Bacterial Peritonitis in Patients with Advanced Cirrhosis?
    Chang Wook Kim
    The Korean Journal of Gastroenterology.2017; 69(2): 93.     CrossRef
  • Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial
    Ji Hoon Park, Mi-Suk Park, So Jung Lee, Woo Kyoung Jeong, Jae Young Lee, Min Jung Park, Kyunghwa Han, Chung Mo Nam, Seong Ho Park, Kyoung Ho Lee
    BMC Cancer.2017;[Epub]     CrossRef
  • Prognostic effect of transarterial chemoembolization–induced complete pathological response in patients undergoing liver resection and transplantation for hepatocellular carcinoma
    Woo‐Hyoung Kang, Shin Hwang, Gi‐Won Song, Young‐Joo Lee, Ki‐Hun Kim, Chul‐Soo Ahn, Deok‐Bog Moon, Dong‐Hwan Jung, Gil‐Chun Park, Sung‐Gyu Lee
    Liver Transplantation.2017; 23(6): 781.     CrossRef
  • Final Report of Unmet Needs of Interferon-Based Therapy for Chronic Hepatitis C in Korea: Basis for Moving into the Direct-Acting Antiviral Era
    Eun Sun Jang, Young Seok Kim, Kyung-Ah Kim, Youn Jae Lee, Woo Jin Chung, In Hee Kim, Byung Seok Lee, Sook-Hyang Jeong
    Gut and Liver.2017; 11(4): 543.     CrossRef
  • Life-sustaining treatment and palliative care in patients with liver cirrhosis - legal, ethical, and practical issues
    Dong Joon Kim, Moon Seok Choi
    Clinical and Molecular Hepatology.2017; 23(2): 115.     CrossRef
  • 3-Dimensional liver volume assessment in patients with hepatitis B virus-related liver cirrhosis during long-term oral nucleos(t)ide analogues therapy
    Chang Hun Lee, In Hee Kim, Jin Chang Moon, Seung Young Seo, Seong Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, Dae Ghon Kim, Jae Do Yang, Hee Chul Yu
    World Journal of Gastroenterology.2017; 23(2): 297.     CrossRef
  • Liver cirrhosis caused by chronic Budd–Chiari syndrome
    Mengjie Lin, Feng Zhang, Yi Wang, Bin Zhang, Wei Zhang, Xiaoping Zou, Ming Zhang, Yuzheng Zhuge
    Medicine.2017; 96(34): e7425.     CrossRef
  • Hospice and Palliative Care in End Stage Liver Disease
    Moon Young Kim
    The Korean Journal of Hospice and Palliative Care.2017; 20(3): 167.     CrossRef
  • Effective viral suppression is necessary to reduce hepatocellular carcinoma development in cirrhotic patients with chronic hepatitis B
    Wei Zhang, Xiaoming Wang, Yu Wang, Xinyan Zhao, Weijia Duan, Qianyi Wang, Xiaoning Wu, Yuanyuan Kong, Hong Ma, Hong You, Xiaojuan Ou, Jidong Jia
    Medicine.2017; 96(44): e8454.     CrossRef
  • Useful Endoscopic Ultrasonography Parameters and a Predictive Model for the Recurrence of Esophageal Varices and Bleeding after Variceal Ligation
    Soung Won Jeong, Hye Soo Kim, Sang Gyune Kim, Jeong-Ju Yoo, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Ji Sung Lee, Young Seok Kim, Boo Sung Kim
    Gut and Liver.2017; 11(6): 843.     CrossRef
  • FATORES PROGNÓSTICOS E MORTALIDADE EM PACIENTES CIRRÓTICOS QUE FORAM INTERNADOS COM HEMORRAGIA DIGESTIVA ALTA VARICOSA EM UM HOSPITAL PÚBLICO
    Haroldo Luiz Jordelino da Luz, Caroline de Medeiros Linhares, Luana Fanha Souto, Bruna Luiza Zonta Ximenes Canfield, Ariane Badotti
    Arquivos Catarinenses de Medicina.2017; 46(1): 97.     CrossRef
  • Hepatic Venous Pressure Gradient Predicts Long-Term Mortality in Patients with Decompensated Cirrhosis
    Tae Yeob Kim, Jae Gon Lee, Joo Hyun Sohn, Ji Yeoun Kim, Sun Min Kim, Jinoo Kim, Woo Kyoung Jeong
    Yonsei Medical Journal.2016; 57(1): 138.     CrossRef
  • The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years?
    Sun Young Yim, Yeon Seok Seo, Chang Ho Jung, Tae Hyung Kim, Jae Min Lee, Eun Sun Kim, Bora Keum, Young Kul Jong, Hyunggin An, Ji Hoon Kim, Hyung Joon Yim, Dong Sik Kim, Yoon Tae Jeen, Jong Eun Yeon, Hong Sik Lee, Hoon Jai Chun, Kwan Soo Byun, Soon Ho Um,
    Liver International.2016; 36(3): 445.     CrossRef
  • Absence of Benefit of Transcatheter Arterial Chemoembolization (TACE) in Patients with Resectable Solitary Hepatocellular Carcinoma
    Tae‐Yong Ha, Shin Hwang, Young‐Joo Lee, Ki‐Hun Kim, Gi‐Young Ko, Dong II Gwon, Chul‐Soo Ahn, Deok‐Bog Moon, Gi‐Won Song, Dong‐Hwan Jung, Han Chu Lee, Young‐Suk Lim, Kang Mo Kim, Ju Hyun Shim, Jeong‐Heon Choi, Sung‐Gyu Lee
    World Journal of Surgery.2016; 40(5): 1200.     CrossRef
  • Proton Pump Inhibitor Therapy Is Associated With Reduction of Early Bleeding Risk After Prophylactic Endoscopic Variceal Band Ligation
    Seong Hee Kang, Hyung Joon Yim, Seung Young Kim, Sang Jun Suh, Jong Jin Hyun, Sung Woo Jung, Young Kul Jung, Ja Seol Koo, Sang Woo Lee
    Medicine.2016; 95(8): e2903.     CrossRef
  • Variceal Bleeding from Anastomosis Site after Total Gastrectomy with Esophagojejunostomy
    Jung Woong Seo, Jeong Han Kim
    The Korean Journal of Gastroenterology.2016; 67(6): 341.     CrossRef
  • Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma
    Jung Hee Kim, Dong Hyun Sinn, Kyunga Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
    Digestive Diseases and Sciences.2016; 61(11): 3354.     CrossRef
  • Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B
    Hye Soo Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Ki Jun Song, Jung Won Park, Yeong Jin Kim, Oidov Baatarkhuu, Kwang-Hyub Han, Sang Hoon Ahn
    Clinical Gastroenterology and Hepatology.2016; 14(11): 1647.     CrossRef
  • Relationship between 25-Hydroxyvitamin D Levels and Liver Fibrosis as Assessed by Transient Elastography in Patients with Chronic Liver Disease
    Bong Jin Ko, Young Seok Kim, Sang Gyune Kim, Jung Hwan Park, Sae Hwan Lee, Soung Won Jeong, Jae Young Jang, Hong Soo Kim, Boo Sung Kim, Sun Mi Kim, Young Don Kim, Gab Jin Cheon, Bo Ra Lee
    Gut and Liver.2016; 10(5): 818.     CrossRef
  • Transplantation with autologous bone marrow‐derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial
    Ki Tae Suk, Jung‐Hwan Yoon, Moon Young Kim, Chang Wook Kim, Ja Kyung Kim, Hana Park, Seong Gyu Hwang, Dong Joon Kim, Byung Seok Lee, Sae Hwan Lee, Hong Soo Kim, Jae Young Jang, Chang‐Hyeong Lee, Byung Seok Kim, Yoon Ok Jang, Mee Yon Cho, Eun Sun Jung, Yon
    Hepatology.2016; 64(6): 2185.     CrossRef
  • Usefulness of Ultrasonographic Scoring System in Diagnosis of Alcoholic Cirrhosis
    Kyoung Min Moon, Soon Koo Baik
    Clinical Ultrasound.2016; 1(2): 92.     CrossRef
  • Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition
    Tae Yeob Kim, Do Seon Song, Hee Yeon Kim, Dong Hyun Sinn, Eileen L. Yoon, Chang Wook Kim, Young Kul Jung, Ki Tae Suk, Sang Soo Lee, Chang Hyeong Lee, Tae Hun Kim, Jeong Han Kim, Won Hyeok Choe, Hyung Joon Yim, Sung Eun Kim, Soon Koo Baik, Byung Seok Lee,
    PLOS ONE.2016; 11(1): e0146745.     CrossRef
  • Clinical features of acute hepatitis E super-infections on chronic hepatitis B
    Chong Chen, Shu-Ye Zhang, Dan-Dan Zhang, Xin-Yan Li, Yu-Ling Zhang, Wei-Xia Li, Jing-Jing Yan, Min Wang, Jing-Na Xun, Chuan Lu, Yun Ling, Yu-Xian Huang, Liang Chen
    World Journal of Gastroenterology.2016; 22(47): 10388.     CrossRef
  • Long-Term Suppression of Viral Replication in Chronic Hepatitis B: Outcomes and Future Directions
    Jae-Jun Shim
    Gut and Liver.2015;[Epub]     CrossRef
  • Prognostic effect of preoperative sequential transcatheter arterial chemoembolization and portal vein embolization for right hepatectomy in patients with solitary hepatocellular carcinoma
    Jeong-Heon Choi, Shin Hwang, Young-Joo Lee, Ki-Hun Kim, Gi-Young Ko, Dong Il Gwon, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Sung-Gyu Lee
    Korean Journal of Hepato-Biliary-Pancreatic Surgery.2015; 19(2): 59.     CrossRef
  • The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B
    In Ku Yo, Oh Sang Kwon, Jin Woong Park, Jong Joon Lee, Jung Hyun Lee, In Sik Won, Sun Young Na, Pil Kyu Jang, Pyung Hwa Park, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim
    Clinical and Molecular Hepatology.2015; 21(1): 32.     CrossRef
  • The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients
    Shin Hwang, Young-Joo Lee, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Sung-Gyu Lee
    Journal of Gastrointestinal Surgery.2015; 19(7): 1281.     CrossRef
  • Disease Progression in Chronic Hepatitis B Patients under Long-Term Antiviral Therapy
    Jin Chang Moon, Seong Hun Kim, In Hee Kim, Chang Hun Lee, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, Dae-Ghon Kim
    Gut and Liver.2015;[Epub]     CrossRef
  • Lower Incidence of Hepatocellular Carcinoma and Cirrhosis in Hepatitis C Patients with Sustained Virological Response by Pegylated Interferon and Ribavirin
    Chansoo Moon, Kyu Sik Jung, Do Young Kim, Oidov Baatarkhuu, Jun Yong Park, Beom Kyung Kim, Seung Up Kim, Sang Hoon Ahn, Kwang-Hyub Han
    Digestive Diseases and Sciences.2015; 60(2): 573.     CrossRef
  • Improvement of liver function and non‐invasive fibrosis markers in hepatitis B virus‐associated cirrhosis: 2 years of entecavir treatment
    Seung Kak Shin, Jeong Han Kim, Hyeonsu Park, Oh Sang Kwon, Hyun Jung Lee, Jong Eun Yeon, Kwan Soo Byun, Sang Jun Suh, Hyung Joon Yim, Yun Soo Kim, Ju Hyun Kim
    Journal of Gastroenterology and Hepatology.2015; 30(12): 1775.     CrossRef
  • Evaluation of portal hypertension by real‐time shear wave elastography in cirrhotic patients
    Tae Yeob Kim, Woo Kyoung Jeong, Joo Hyun Sohn, Jinoo Kim, Min Yeong Kim, Yongsoo Kim
    Liver International.2015; 35(11): 2416.     CrossRef
  • Liver Stiffness Measurement, Better than APRI, Fibroindex, Fib-4, and NBI Gastroscopy, Predicts Portal Hypertension in Patients with Cirrhosis
    Wei Zhang, Liqiong Wang, Lei Wang, Gang Li, Aoshuang Huang, Ping Yin, Zhenhua Yang, Changquan Ling, Lingtai Wang
    Cell Biochemistry and Biophysics.2015; 71(2): 865.     CrossRef
  • What we know about paracentesis induced circulatory dysfunction?
    Jeong Han Kim
    Clinical and Molecular Hepatology.2015; 21(4): 349.     CrossRef
  • Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B
    Hyo Jung Cho, Soon Sun Kim, Seun Joo Ahn, Joo Han Park, Dong Joon Kim, Young Bae Kim, Sung Won Cho, Jae Youn Cheong
    Clinical and Molecular Hepatology.2014; 20(4): 347.     CrossRef
  • Prevention of Variceal Rebleeding According to the Dose of Propranolol
    Jae Young Jang, Woong Cheul Lee
    Korean Journal of Medicine.2014; 86(1): 30.     CrossRef
  • Sarcopenia as a Useful Predictor for Long-Term Mortality in Cirrhotic Patients with Ascites
    Tae Yeob Kim, Min Yeong Kim, Joo Hyun Sohn, Sun Min Kim, Jeong Ah Ryu, Sanghyeok Lim, Youngsoo Kim
    Journal of Korean Medical Science.2014; 29(9): 1253.     CrossRef
  • Clinically Severe Portal Hypertension: Role of Multi-detector Row CT Features in Diagnosis
    Ji Young Lee, Tae Yeob Kim, Woo Kyoung Jeong, Yongsoo Kim, Jinoo Kim, Kyoung Won Kim, Young Hwan Kim, Joo Hyun Sohn
    Digestive Diseases and Sciences.2014; 59(9): 2333.     CrossRef
  • Cyanoacrylate Injection Compared with Band Ligation for Acute Gastric Variceal Hemorrhage: A Meta-Analysis of Randomized Controlled Trials and Observational Studies
    Xiaohua Ye, Jiaping Huai, Yanping Chen
    Gastroenterology Research and Practice.2014; 2014: 1.     CrossRef
  • Clinical Features of Non-alcoholic Fatty Liver Disease in Cryptogenic Hepatocellular Carcinoma
    Min Young Rim, Oh Sang Kwon, Minsu Ha, Ju Seung Kim, Kwang Il Ko, Dong Kyu Kim, Pil Kyu Jang, Jung Yoon Han, Pyung Hwa Park, Young Kul Jung, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim
    The Korean Journal of Gastroenterology.2014; 63(5): 292.     CrossRef
  • Histological improvement following administration of autologous bone marrow‐derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study
    Yoon Ok Jang, Young Ju Kim, Soon Koo Baik, Moon Young Kim, Young Woo Eom, Mee Yon Cho, Hong Jun Park, So Yeon Park, Bo Ra Kim, Jae Woo Kim, Hyun Soo Kim, Sang Ok Kwon, Eun Hee Choi, Yong Man Kim
    Liver International.2014; 34(1): 33.     CrossRef
  • Relationship between Tetrahydrobiopterin and Portal Hypertension in Patients with Chronic Liver Disease
    Won Ki Hong, Kwang Yong Shim, Soon Koo Baik, Moon Young Kim, Mee Yon Cho, Yoon Ok Jang, Young Shik Park, Jin Han, Gaeun Kim, Youn Zoo Cho, Hye Won Hwang, Jin Hyung Lee, Myeong Hun Chae, Sang Ok Kwon
    Journal of Korean Medical Science.2014; 29(3): 392.     CrossRef
  • Use of the Delta Neutrophil Index as a Prognostic Factor of Mortality in Patients with Spontaneous Bacterial Peritonitis: Implications of a Simple and Useful Marker
    Tae Seop Lim, Beom Kyung Kim, Jong Wook Lee, Young Ki Lee, Sooyun Chang, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Chae Yoon Chon, Jun Yong Park, Charles C. Caldwell
    PLoS ONE.2014; 9(1): e86884.     CrossRef
  • Alcoholic liver disease: Treatment
    Ki Tae Suk
    World Journal of Gastroenterology.2014; 20(36): 12934.     CrossRef
  • Association of polymorphism in MicroRNA 219‐1 with clearance of hepatitis B virus infection
    Jae Youn Cheong, Hyoung Doo Shin, Yoon Jun Kim, Sung Won Cho
    Journal of Medical Virology.2013; 85(5): 808.     CrossRef
  • Caspase-cleaved fragments of cytokeratin-18 as a marker of inflammatory activity in chronic hepatitis B virus infection
    Chang Bum Bae, Soon Sun Kim, Seun Joo Ahn, Hyo Jung Cho, Sei Rhan Kim, Sun Young Park, Ga Won Song, Dong Joon Kim, Seong Gyu Hwang, Jin Mo Yang, Young Bae Kim, Young Nyun Park, Sung Jae Shin, Sung Won Cho, Jae Youn Cheong
    Journal of Clinical Virology.2013; 58(4): 641.     CrossRef
  • The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data
    Won Ki Hong, Moon Young Kim, Soon Koo Baik, Seung Yong Shin, Jung Min Kim, Yong Seok Kang, Yoo Li Lim, Young Ju Kim, Youn Zoo Cho, Hye Won Hwang, Jin Hyung Lee, Myeong Hun Chae, Hyoun A Kim, Hye Won Kang, Sang Ok Kwon
    Clinical and Molecular Hepatology.2013; 19(4): 370.     CrossRef
  • Prevention and Management of Variceal Hemorrhage
    Dong Hyun Kim, Jun Yong Park
    International Journal of Hepatology.2013; 2013: 1.     CrossRef
  • Comparison of Endoscopic Variceal Ligation and Endoscopic Variceal Obliteration in Patients with GOV1 Bleeding
    Hyoung Ju Hong, Chung Hwan Jun, Du Hyeon Lee, Eun Ae Cho, Seon Young Park, Sung Bum Cho, Chang Hwan Park, Young Eun Joo, HyunSoo Kim, Sung Kyu Choi, Jong Sun Rew
    Chonnam Medical Journal.2013; 49(1): 14.     CrossRef
  • The Korean National Liver Cancer Surveillance Program: Experience of a Single Healthcare Center in 2011
    Jae-Jun Shim, Hyun Jin Park, Jung-Wook Kim, Eun Jung Hwang, Chang Kyun Lee, Jae Young Jang, Seong Jin Park, Hyun Rim Choi, Byung-Ho Kim
    Korean Journal of Medicine.2013; 84(5): 672.     CrossRef
  • Spontaneous Healing of Gastric Perforation after Endoscopic Ligation for Gastric Varices
    Jung Ho Kim, Hong Dae Ahn, Kwang An Kwon, Yoon Jae Kim, Jun-Won Chung, Dong Kyun Park, Ju Hyun Kim
    Journal of Korean Medical Science.2013; 28(4): 624.     CrossRef
  • A Case of Spontaneous Bacterial Peritonitis Caused byListeria monocytogenes
    Byung Sihk Kim, Tae Yeob Kim, Ji Yeoun Kim, Kyo Sang Yoo, Yong Chul Jeon, Dong Soo Han, Joo Hyun Sohn, Jieun Kim
    The Korean Journal of Gastroenterology.2013; 62(3): 179.     CrossRef
  • Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study
    Se Young Jang, Go Heun Kim, Soo Young Park, Chang Min Cho, Won Young Tak, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Jae Myeong Lee, Sang Gyune Kim, Dae Yong Kim, Young Seok Kim, Se-Ok Lee, Yang Won Min, Joon Hyeok Lee, Seung Woon Paik, Byung Chul Yoo,
    Clinical and Molecular Hepatology.2012; 18(4): 368.     CrossRef
  • Spontaneous Bacterial Peritonitis with Sepsis Caused byEnterococcus hirae
    Jong Seop Sim, Hyoung Su Kim, Ki Jong Oh, Myung Soo Park, Eun Ju Jung, Youn Joo Jung, Dae Gil Kang, Seung In Seo, Won Jin Kim, Myoung Kuk Jang
    Journal of Korean Medical Science.2012; 27(12): 1598.     CrossRef
  • 65,535 View
  • 191 Download
  • Crossref